GSK

About

Pharmaceutical company that purchased Sinclair's resveratrol research for 720 million dollars, then abandoned it after finding no benefit

Cast within

No topic-region cast yet — this appears once GSK's compiled claims are aligned into a topic region's argument tree.

Claims by GSK (0)

No claims found for this person.

Your notes

Loading notes...